Glaucoma prize for discovery of form of circulation within the human eye

Article

Dr Yeni H. Yucel, an ophthalmic pathologist at St. Michael's Hospital, has won the prestigious 2010 Lewis Rudin Glaucoma Prize from the New York Academy of Medicine.

Dr Yeni H. Yucel, an ophthalmic pathologist at St. Michael's Hospital, has won the prestigious 2010 Lewis Rudin Glaucoma Prize from the New York Academy of Medicine.

Dr Yucel received the $50,000 award for discovering a form of circulation within the human eye that may lead to new treatments for glaucoma and eye tumours.

His work dispelled the longstanding assumption that the eye has no lymphatics, the channels responsible for pumping fluid and waste out of tissues.

Glaucoma affects more than 66 million people worldwide and is the second-leading cause of irreversible blindness.

The discovery of lymphatic circulation in the eye also refutes the assumption that the eye is not connected to the body's immune system. In addition to draining fluid and clearing proteins, lymphatics monitor immune responses. This discovery has major implications for understanding eye inflammations and the spread of eye tumours.

Dr Yücel's work, Identification of lymphatics in the ciliary body of the human eye: A novel uveolympahtic outflow pathway, was published in the journal Experimental Eye Research in November 2009.

The Rudin Glaucoma Prize recognizes the most significant scholarly article on glaucoma published in a peer-reviewed journal in the prior calendar year. Recipients are nominated by their peers and a winner is chosen by The New York Academy of Medicine's Lewis Rudin Prize Selection Committee and approved by the academy's Board of Trustees. The prize was established by Lewis and Jack Rudin, New York builders and philanthropists.

“This work opens entirely new avenues for understanding the cause and treatment of glaucoma and its implications are profound,” said Dr David Abramson, chair of the prize selection committee.

Contributors to the article include Miles G. Johnston, Tina Ly, Manoj Patel, Brian Drake, Ersin Gümü, Stephan A. Fraenkl, Sara Moore, Dalia Tobbia, Dianna Armstrong, Eva Horvath, and Neeru Gupta.

Source: Leslie ShepherdSt. Michael's Hospital

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.